Establishing a diagnostic road map for MUTYH-associated polyposis
Ester Borras1, Melissa W Taggart, Patrick M Lynch
1Authors' Affiliations: Departments of Clinical Cancer Prevention, Pathology, and Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Summary
This study highlights the need to examine serrated polyps in patients with few polyps (oligopolyposis) and suggests screening for the KRAS mutation to guide genetic testing strategies.
Area of Science:
- Genetics
- Gastroenterology
- Oncology
Background:
- MUTYH-associated polyposis (MAP) is an inherited condition predisposing to colorectal cancer.
- Oligopolyposis, characterized by a small number of polyps, can present diagnostic challenges.
- Serrated polyps are increasingly recognized as important in colorectal cancer development.
Purpose of the Study:
- To evaluate the diagnostic significance of serrated polyps in MUTYH-associated polyposis.
- To explore the utility of somatic KRAS mutation screening in polyps from patients with oligopolyposis.
- To inform genetic testing strategies for hereditary polyposis syndromes.
Main Methods:
- Analysis of cases from the EPIPOLIP cohort with MUTYH-associated polyposis.
- Inclusion of serrated polyps in the diagnostic work-up.
- Screening of polyps for the specific somatic c.34G>T KRAS mutation.
Main Results:
- Confirmation of the importance of including serrated polyps in the evaluation of oligopolyposis.
- Evidence suggesting a role for screening polyps for the KRAS mutation.
- Data enabling the implementation of a population-based genetic testing strategy.
Conclusions:
- Serrated polyps are crucial in the diagnostic work-up for MUTYH-associated polyposis, especially in oligopolyposis.
- KRAS mutation screening in polyps may aid in identifying patients requiring genetic testing.
- Findings support a refined genetic testing approach for hereditary polyposis.
